A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

Cited by (1,005)

Items 701–800 of 1,005

1. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML
   D. C. van der Plas, Gerard C. Grosveld, A. Hagemeijer · 1991 · Cancer Genetics and Cytogenetics
2. Rearrangement in the Breakpoint Cluster Region and the Clinical Course in Philadelphia-Negative Chronic Myelogenous Leukemia
   Razelle Kurzrock, MARK B. BLICK, Moshe Talpaz, WILLIAM S. VELASQUEZ, JOSE M. TRUJILLO, NICOLA M. KOUTTAB, WILLIAM S. KLOETZER, Ralph B. Arlinghaus, JORDAN U. GUTTERMAN · 1986 · Annals of Internal Medicine
3. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
   Farhad Ravandi, Partow Kebriaei · 2009 · Hematology/Oncology Clinics of North America
4. Detection of Gene Rearrangements in Targeted Clinical Next-Generation Sequencing
   Haley Abel, Hussam Al‐Kateb, Catherine E. Cottrell, Andrew J. Bredemeyer, Colin C. Pritchard, Allie H. Grossmann, Michelle L. Wallander, John D. Pfeifer, Christina M. Lockwood, Eric James Duncavage · 2014 · Journal of Molecular Diagnostics
5. The SH2 domain of P210BCR/ABL is not required for the transformation of hematopoietic factor-dependent cells
   RL Jr Ilaria, Richard A. Van Etten · 1995 · Blood
6. Aneuploidy and malignancy: an unsolved equation
   Pranab Dey · 2004 · Journal of Clinical Pathology
7. Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies
   Armin Wolf, Philippe Couttet, Min Dong, Olivier Grenet, Marcia I. Heron, Ursula Junker, Ulrich Wilhelm Laengle, David Ledieu, Estelle Marrer, Anja Nussher et al. · 2010 · Leukemia Research
8. The human c-ros gene (ROS) is located at chromosome region 6q16----6q22.
   L Nagarajan, Elaine Louie, Yoshihide Tsujimoto, Piero C. Balduzzi, Kay Huebner, Carlo Maria Croce · 1986 · Proceedings of the National Academy of Sciences
9. Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
   Irina Sadovnik, Andrea Hoelbl‐Kovacic, Harald Herrmann, Gregor Eisenwort, Sabine Cerny‐Reiterer, Wolfgang Warsch, Gregor Hoermann, Georg Greiner, Katharina Blatt, Barbara Peter et al. · 2015 · Clinical Cancer Research
10. New tyrosine kinase inhibitors in chronic myeloid leukemia.
    Giovanni Martinelli, Simona Soverini, Gianantonio Rosti, Daniela Cilloni, Michele Baccarani · 2005 · PubMed
11. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities
    Daniel Primo, María Dolores Tabernero, Ana Rasillo, José María Sayagués, A B Espinosa, Carmen Chillón, Ramón García‐Sánz, Norma Carmen Gutierrez, Manuel Giralt, A Hagemeijer et al. · 2003 · Leukemia
12. Establishment of a Reproducible Model of Chronic-Phase Chronic Myeloid Leukemia in NOD/SCID Mice Using Blood-Derived Mononuclear or CD34+ Cells
    Ian D. Lewis, Louise A. McDiarmid, Leanne M. Samels, L. Bik To, Timothy P. Hughes · 1998 · Blood
13. Localisation of 5S ribosomal RNA genes on human chromosome 1
    Dale M. Steffensen, Patricia A. Duffey, Wolf Prensky · 1974 · Nature
14. Disease Features in Acute Myeloid Leukemia with t(8;21)(q22;q22). Influence of Age, Secondary Karyotype Abnormalities, CD19 Status, and Extramedullar Leukemia on Survival
    K. Rege, G. John Swansbury, Ayad Atra, Clive Horton, Toon Min, Melissa Dainton, Estella Matutes, Muheez Alani Durosinmi, J. G. Treleaven, R Powles et al. · 2000 · Leukemia & lymphoma/Leukemia and lymphoma
15. Localization of gelsolin proximal to ABL on chromosome 9.
    David J. Kwiatkowski, Carol A. Westbrook, G.A.P. Bruns, Cynthia Casson Morton · 1988 · PubMed
16. Distinguishing the Philadelphia Chromosome of Acute Lymphoblastic Leukemia from Its Counterpart in Chronic Myelogenous Leukemia
    Sjoerd Rodenhuis, Lou A. Smets, Rosalyn M. Slater, H. Behrendt, Anjo J.P. Veerman · 1985 · New England Journal of Medicine
17. Optical genome mapping for structural variation analysis in hematologic malignancies
    Adam C. Smith, Kornelia Neveling, Rashmi Kanagal‐Shamanna · 2022 · American Journal of Hematology
18. Signaling Networks Associated with BCR–ABL–Dependent Transformation
    Lori Hazlehurst, Nadine N. Bewry, Rajesh R. Nair, Javier A. Pinilla-Ibarz · 2009 · Cancer Control
19. Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors
    Wei Wang, Jörge E. Cortes, Pei Lin, Michael W. Beaty, Di Ai, Hesham M. Amin, Timothy J. McDonnell, Chi Young Ok, Hagop M. Kantarjian, Leonard Jeffrey Medeiros et al. · 2015 · Blood
20. Focal chromosomal copy number aberrations in cancer—Needles in a genome haystack
    Oscar Krijgsman, Beatriz G. Carvalho, Gerrit A. Meijer, Renske D.M. Steenbergen, Bauke Ylstra · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
21. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene
    Fergal C. Kelleher, Ray McDermott · 2010 · European Journal of Cancer
22. Genomic instability and radiation
    John B. Little · 2003 · Journal of Radiological Protection
23. Evaluation of antileukaemic effects of rapamycin in patients with imatinib‐resistant chronic myeloid leukaemia
    Christian Sillaber, Matthias Mayerhofer, Alexandra Böhm, Anja Vales, Alexander Gruze, Karl J. Aichberger, Harald Esterbauer, Michael Pfeilstöcker, Wolfgang R. Sperr, Winfried Franz Pickl et al. · 2007 · European Journal of Clinical Investigation
24. Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options
    Steffen Koschmieder, David L.P. Vetrie · 2017 · Seminars in Cancer Biology
25. Therapy-Related Chronic Myeloid Leukemia: An Epidemiological, Clinical and Pathogenetic Appraisal
    Ricardo C.T. Aguiar · 1998 · Leukemia & lymphoma/Leukemia and lymphoma
26. Recent Advancements in the Treatment of Chronic Myelogenous Leukemia
    Michael E O'Dwyer, Michael J. Mauro, Brian J. Druker · 2002 · Annual Review of Medicine
27. Cytogenetic studies of early myeloid progenitor compartments in Ph1- positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated as well as newly diagnosed patients
    ID Dube, DK Kalousek, Laure Coulombel, CM Gupta, Connie J. Eaves, AC Eaves · 1984 · Blood
28. Effect of herbimycin A, an antagonist of tyrosine kinase, on bcr/abl oncoprotein-associated cell proliferations: abrogative effect on the transformation of murine hematopoietic cells by transfection of a retroviral vector expressing oncoprotein P210bcr/abl and preferential inhibition on Ph1-positive leukemia cell growth
    Masaru Okabe, Y Uehara, T. Miyagishima, Toshiyuki Itaya, Motoyoshi Tanaka, Y Kunieda, M Kurosawa, T Miyazaki · 1992 · Blood
29. Quantitative determination of the hybrid Bcr‐Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy
    Marie‐Claire Malinge, François‐Xavier Mahon, Marie‐Hélène Delfau‐Larue, Laurence M. Daheron, Alain Kitzis, François Guilhot, Joseph Tanzer, Bernard Grandchamp · 1992 · British Journal of Haematology
30. Chromosomes and causation of human cancer and leukemia. XXIV. Unusual and complex Ph1 translocations and their clinical significance
    Shin‐ichi Sonta, AA Sandberg · 1977 · Blood
31. Chronic Myeloid Leukemia: Mechanisms of Resistance and Treatment
    Jabbour, Elias, Parikh, Sameer A., Kantarjian, Hagop, Cortes, Jorge · 2011 · Hematology/Oncology Clinics of North America
32. Extracellular vesicles and blood diseases
    Shosaku� Nomura · 2017 · International Journal of Hematology
33. Molecular Profiling of Cancer—The Future of Personalized Cancer Medicine: A Primer on Cancer Biology and the Tools Necessary to Bring Molecular Testing to the Clinic
    Thomas P. Stricker, Daniel V.T. Catenacci, Tanguy Y. Seiwert · 2011 · Seminars in Oncology
34. The consequences of chromosomal aneuploidy on the transcriptome of cancer cells
    Thomas Ried, Yue Hu, Michael J. Difilippantonio, Β. Michael Ghadimi, Marian Grade, Jordi Camps · 2012 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
35. Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec)
    Kun-Eek Kil, Yu‐Shin Ding, Kuo‐Shyan Lin, David Alexoff, Sung Won Kim, Colleen E. Shea, Youwen Xu, Lisa Muench, Joanna S. Fowler · 2007 · Nuclear Medicine and Biology
36. History and evolution of cytogenetics
    Malcolm Andrew Ferguson-Smith · 2015 · Molecular Cytogenetics
37. p210BCR-ABL inhibits SDF-1 Chemotactic Response via Alteration of CXCR4 Signaling and Down-regulation of CXCR4 Expression
    Jean‐François Geay, Dorothée Selimoglu‐Buet, Yanyan Zhang, Adlen Foudi, Peggy Jarrier-Gaillard, Magali Berthebaud, Ali G. Turhan, William Vainchenker, Fawzia Louache · 2005 · Cancer Research
38. Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party
    Fausto Castagnetti, Francesca Palandri, Marilina Amabile, Nicoletta Testoni, Simona Luatti, Simona Soverini, Ilaria Iacobucci, Massimo Breccia, Giovanna Rege Cambrin, Fabio Stagno et al. · 2009 · Blood
39. BIOLOGY OF CHRONIC MYELOGENOUS LEUKEMIA
    Catherine M. Verfaillie · 1998 · Hematology/Oncology Clinics of North America
40. Identification of de novo chromosomal markers and derivatives by spectral karyotyping
    Bassem R. Haddad, Evelin Schröck, Jeanne Monroy Meck, Janet M. Cowan, Hannah Young, Malcolm Andrew Ferguson-Smith, Stanislas du Manoir, Thomas Ried · 1998 · Human Genetics
41. The biology of signal transduction inhibition: Basic science to novel therapies
    James D. Griffin · 2001 · Seminars in Oncology
42. Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukaemia
    Anthony M. Potter, Ann E. Watmore, Patricia Cooke, J S Lilleyman, Robert J. Sokol · 1981 · British Journal of Cancer
43. Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice
    JW Voncken, Christopher M. Morris, P K Pattengale, Gunther Dennert, C Kikly, John Groffen, Nora Heisterkamp · 1992 · Blood
44. Inhibition of BCR-ABL Expression With Antisense Oligodeoxynucleotides Restores β1 Integrin-Mediated Adhesion and Proliferation Inhibition in Chronic Myelogenous Leukemia Hematopoietic Progenitors
    Ravi Bhatia, Catherine M. Verfaillie · 1998 · Blood
45. Chromosome Banding Studies in Philadelphia Chromosome Positive Myeloid Leukaemia
    Sylvia D. Lawler, Frances P. O’Malley, Daphne Lobb · 1976 · Scandinavian Journal of Haematology
46. The INK4-ARF (CDKN2A/B) Locus in Hematopoiesis and BCR-ABL-induced Leukemias
    Richard Thomas Williams, Charles J. Sherr · 2008 · Cold Spring Harbor Symposia on Quantitative Biology
47. Expression of p210 and p190 BCL-ABL due to alternative splicing in chronic myelogenous leukaemia
    Brian Dennis Lichty, Armand Keating, Jeannie Callum, Karen W L Yee, Ruth Croxford, George Corpus, Bevoline Nwachukwu, Peter Kim, Joyce Guo, Suzanne Kamel‐Reid · 1998 · British Journal of Haematology
48. The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis
    Brenton G. Mar, Dereck Dokyi Amakye, Iannis Aifantis, Silvia Buonamici · 2011 · Leukemia
49. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia
    Jesús Duque‐Afonso, Jue Feng, Florian Scherer, Chiou-Hong Lin, Stephen H.K. Wong, Zhong Wang, 正幸 岩崎, Michael L. Cleary · 2015 · Journal of Clinical Investigation
50. CD34+/CD38- stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin
    Harald Herrmann, Sabine Cerny‐Reiterer, Karoline Veronika Gleixner, K. Blatt, Susanne Herndlhofer, Werner Rabitsch, E. Jager, Gerlinde Mitterbauer‐Hohendanner, Berthold Streubel, Edgar Selzer et al. · 2011 · Haematologica
51. Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?
    Alessandra Iurlo, Emanuela Orsi, Daniele Cattaneo, Veronica Resi, Cristina Bucelli, Nicola Orofino, Mariarita Sciumé, Chiara Elena, Valeria Grancini, Dario Consonni et al. · 2015 · Oncotarget
52. The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment
    Laura N Eadie, Phuoc Giau Dang, V. A. Saunders, David T. O. Yeung, Michael Philip Osborn, Andrew Grigg, Timothy P. Hughes, Deborah L. White · 2016 · Leukemia
53. Imatinib Mesylate
    Cornelius Florian Waller · 2009 · Recent results in cancer research/Recent Results in Cancer Research
54. Dual tyrosine kinase inhibitors in chronic myeloid leukemia
    Giovanni Martinelli, Simona Soverini, Gianantonio Rosti, Michele Baccarani · 2005 · Leukemia
55. BCR-ABL in Chronic Myelogenous Leukemia – How Does It Work?
    John M. Goldman, Junia V. Melo · 2008 · Acta Haematologica
56. Chronic myelogenous leukemia: molecular and cellular aspects
    Günther Pasternak, Andreas Hochhaus, Beate S. Schultheis, R. Hehlmann · 1998 · Journal of Cancer Research and Clinical Oncology
57. CLINICAL COURSE AND THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND CHEMOTHERAPY
    Hagop M. Kantarjian, Francis Joseph Giles, Susan Mary O'Brien, Moshe Talpaz · 1998 · Hematology/Oncology Clinics of North America
58. Cloning and characterization of the T(15;17) translocation breakpoint region in acute promyelocytic leukemia
    Richard S. Lemons, David S. Eilender, Richard A. Waldmann, Matthew Rebentisch, Ann‐Kristin Frej, David H. Ledbetter, Cheryl L. Willman, Thomas S. McConnell, Peter O'Connell · 1990 · Genes Chromosomes and Cancer
59. Bipotential cell differentiation of KU-812: evidence of a hybrid cell line that differentiates into basophils and macrophage-like cells
    T Fukuda, Kenji Kishi, Yoshihisa Ohnishi, A Shibata · 1987 · Blood
60. Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues.
    Richard Dale Huhn, Marshall R. Posner, SI Rayter, J. Gordon Foulkes, A. Raymond Frackelton · 1987 · Proceedings of the National Academy of Sciences
61. Chromosomal aberrations in chronic B-cell lymphocytic leukemia
    Gösta Gahrton, K.‐H. ROBÈRT · 1982 · Cancer Genetics and Cytogenetics
62. Managing resistance in chronic myeloid leukemia
    Sameek Roychowdhury, Moshe Talpaz · 2011 · Blood Reviews
63. Fusion Genes and RNAs in Cancer Development
    Kenzui Taniue, Nobuyoshi Akimitsu · 2021 · Non-Coding RNA
64. Acute Renal Failure Secondary to Imatinib Mesylate Treatment in Chronic Myeloid Leukemia
    Mónica Pou, Núria Saval, Manel Vera, Anna Saurina, Manel Solé, Francisco Cervantes, Albert Botey · 2003 · Leukemia & lymphoma/Leukemia and lymphoma
65. Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine
    Célia Dupain, Anne C. Harttrampf, Giorgia Urbinati, Birgit Geoerger, Liliane Massaad-Massade · 2017 · Molecular Therapy — Nucleic Acids
66. Clonal Cytogenetic Abnormalities in Philadelphia Chromosome Negative Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib
    Marc Loriaux, Michael W. Deininger · 2004 · Leukemia & lymphoma/Leukemia and lymphoma
67. Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors.
    Nikolas C. C. von Bubnoff, Darren R. Veach, W. Todd Miller, Wanqing Li, Jana Sänger, Christian Peschel, William G. Bornmann, Bayard Clarkson, Justus Duyster · 2003 · PubMed
68. A familial reciprocal translocation t(3;7) (p21.1;p13) associated with the Greig polysyndactyly‐craniofacial anomalies syndrome
    Niels Tommerup, Frank Nielsen, John M. Opitz · 1983 · American Journal of Medical Genetics
69. The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
    Anwar N. Mohamed, Pamela Pemberton, Jeffrey A. Zonder, Charles Alan Schiffer · 2003 · PubMed
70. Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity
    Garth L. Nicolson · 1984 · Clinical & Experimental Metastasis
71. A NEW TRANSLOCATION RELATED TO THE PHILADELPHIA CHROMOSOME
    Isamu Hayata, Surabhi Kakati, A.A. Sandberg · 1973 · The Lancet
72. Hairy cell leukemia: An unusual lymphoproliferative disease.A study of 24 patients
    Harvey M. Golomb · 1978 · Cancer
73. Cytogenetic studies in acute lymphocytic leukemia: Special emphasis in long‐term survival
    Jacqueline Whang‐Peng, Turid Knutsen, John L. Ziegler, Brigid G. Leventhal · 1976 · Medical and Pediatric Oncology
74. Improved resolution of flow cytometric measurements of hoechst‐ and chromomycin‐A3‐stained human chromosomes after addition of citrate and sulfite
    Ger van den Engh, Barb Trask, Joe W. Gray, Peter M. Lansdorp · 1988 · Cytometry
75. Specific chromosome anomalies and predisposition to human breast, renal cell, and colorectal carcinoma
    Sen Pathak, Angela Goodacre · 1986 · Cancer Genetics and Cytogenetics
76. Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemia
    Robert Jr. Roskoski · 2022 · Pharmacological Research
77. A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
    John Francis Seymour, D. W. Kim, E Rubin, Abebe Haregewoin, Jason Clark, P Watson, Timothy P. Hughes, Inge Høgh Dufva, Javier López Jiménez, François‐Xavier Mahon et al. · 2014 · Blood Cancer Journal
78. MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML
    Sukanya Suresh, Lynn M. R. McCallum, Wanhua Lu, Noureddine Lazar, Bernard Perbal, Alexandra E. Irvine · 2011 · Journal of Cell Communication and Signaling
79. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host‐directed therapeutics
    Thomas R. Hawn, Javeed Ali Shah, Daniel Kalman · 2015 · Immunological Reviews
80. Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions
    Katharina Rothe, Vanessa Porter, Xiaoyan Jiang · 2019 · International Journal of Molecular Sciences
81. After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
    Martha Wadleigh, Daniel J. DeAngelo, James D. Griffin, Richard Maury Stone · 2004 · Blood
82. Activation of the abl oncogene in murine and human leukemias
    James B. Konopka, Owen N. Witte · 1985 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
83. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis
    A Foti, HG Ahuja, Steven L. Allen, Prasad R. K. Koduru, MW Schuster, Philip Schulman, Menashe Bar‐Eli, MJ Cline · 1991 · Blood
84. X-linked clonality testing: interpretation and limitations
    George L. Chen, Josef T. Prchal · 2007 · Blood
85. Long‐term outcomes in the second‐line treatment of chronic myeloid leukemia
    Elias Joseph Jabbour, Jörge E. Cortes, Hagop M. Kantarjian · 2010 · Cancer
86. Treating cancer's kinase 'addiction'
    Jose M Baselga, Joaquı́n Arribas · 2004 · Nature Medicine
87. Patterns of Chromosomal Aberrations in Solid Tumors
    Marian Grade, Michael J. Difilippantonio, Jordi Camps · 2015 · Recent results in cancer research/Recent Results in Cancer Research
88. The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias
    Taira Maekawa, Eishi Ashihara, Shinya H Kimura · 2007 · International Journal of Clinical Oncology
89. Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy
    Gautam M. Borthakur, Hagop M. Kantarjian, George Q. Daley, Moshe Talpaz, Susan Mary O'Brien, Guillermo Garcia‐Manero, Francis Joseph Giles, Stefan H Faderl, Mary M. Sugrue, Jörge E. Cortes · 2005 · Cancer
90. Externalization and binding of galectin-1 on cell surface of K562 cells upon erythroid differentiation
    Didier Lutomski, Magali Fouillit, Philippe Bourin, D MELLOTTEE, Nicole Denize, Michel Pontet, Dominique Bladier, Michel Caron, Raymonde Joubert‐Caron · 1997 · Glycobiology
91. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia [see comments]
    Koiti Inokuchi, Takuya K. Inoue, Arinobu Tojo, Makoto Futaki, K Miyake, Toshiyuki Yamada, Y Tanabe, I Ohki, K Dan, Katsusuke OZAWA · 1991 · Blood
92. 5 Cytogenetics in CLL and related disorders
    Gunnar Juliusson, Gösta Gahrton · 1993 · Baillière s Clinical Haematology
93. Humanbcr-abl gene has a lethal effect on embryogenesis
    Nora Heisterkamp, Guido W Jenster, Dimitris Kioussis, Paul K. Pattengale, John Groffen · 1991 · Transgenic Research
94. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed Myeloid Cells
    Arun Bhat, Kathryn S. Kolibaba, Tsukasa Oda, Sayuri Ohno-Jones, Conor Heaney, Brian J. Druker · 1997 · Journal of Biological Chemistry
95. Issues in the Pathology and Diagnosis of the Chronic Myeloproliferative Disorders and the Myelodysplastic Syndromes
    Jerome I. Dickstein, James W. Vardiman · 1993 · American Journal of Clinical Pathology
96. Cytogenetic and molecular analysis in Philadelphia negative CML
    DC van der Plas, AB Hermans, D Soekarman, EM Smit, Annelies de Klein, Nicole Véronique Smadja, G. Alimena, Robert Goudsmit, Gerard C. Grosveld, A Hagemeijer · 1989 · Blood
97. Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Arthur L. Hooberman, John J. Carrino, David S. Leibowitz, Janet D. Rowley, Michelle M. Le Beau, Z. A. Arlin, Carol A. Westbrook · 1989 · Proceedings of the National Academy of Sciences
98. The Philadelphia chromosome in human macrophages
    David W. Golde, C Burgaleta, Sparkes Rs, MJ Cline · 1977 · Blood
99. Improving outcomes for high‐risk ALL: Translating new discoveries into clinical care
    Stephen P. Hunger, Elizabeth A. Raetz, Mignon L. Loh, Charles Grenfell Mullighan · 2011 · Pediatric Blood & Cancer
100. An Efficient Method for Identifying Gene Fusions by Targeted RNA Sequencing from Fresh Frozen and FFPE Samples
     Jonathan Adam Scolnick, Michelle T. Dimon, I‐Ching Wang, Stephanie C. Huelga, Douglas A. Amorese · 2015 · PLoS ONE